Effects of Adalimumab versus Placebo on Risk of Symptom Worsening in Psoriasis and Subsequent Impacts on Health-Related Quality-of-Life: Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled, Multicentre Clinical Trials

Author: Papp Kim A.  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.31, Iss.1, 2011-01, pp. : 51-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content